Parkside Financial Bank & Trust
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1455267
SAINT LOUIS, MO
Position in REGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$149,891
-$64,688 QoQ
Shares Held
194
-30.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Parkside Financial Bank & Trust holds $38,819,782 across 131 Biotechnology names. REGN ranks #5 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
1,329,164 | $36,817,842 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
735 | $328,206 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
4,890 | $316,040 | |
| 4 | TECH |
BIO-TECHNE Corp
|
3,722 | $194,511 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
194 | $149,891 | |
| 6 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
4,027 | $99,708 | |
| 7 | MRNA |
Moderna, Inc.
|
1,807 | $91,794 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,050 | $88,116 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $149,891 | 194 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $214,579 | 278 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $91,649 | 163 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $74,550 | 142 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $117,966 | 186 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $136,766 | 192 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $204,991 | 195 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $200,746 | 191 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $181,909 | 189 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $164,240 | 187 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $133,319 | 162 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $104,906 | 146 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $113,390 | 138 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $88,021 | 122 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $72,330 | 105 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $45,516 | 77 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $67,048 | 96 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $51,784 | 82 | Shares | Defined | 2022-03-01 | |
| 2021-09-30 | $44,177 | 73 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $34,629 | 62 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $23,656 | 50 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $49,760 | 103 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $31,906 | 57 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $34,923 | 56 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $30,273 | 62 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||